Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

Charlson ES, Diamond JM, Bittinger K, Fitzgerald AS, Yadav A, Haas AR, Bushman FD, Collman RG.

Am J Respir Crit Care Med. 2012 Sep 15;186(6):536-45. doi: 10.1164/rccm.201204-0693OC. Epub 2012 Jul 12.

2.

Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome.

Willner DL, Hugenholtz P, Yerkovich ST, Tan ME, Daly JN, Lachner N, Hopkins PM, Chambers DC.

Am J Respir Crit Care Med. 2013 Mar 15;187(6):640-7. doi: 10.1164/rccm.201209-1680OC. Epub 2013 Jan 17.

PMID:
23328523
3.

Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.

Valentine VG, Gupta MR, Walker JE Jr, Seoane L, Bonvillain RW, Lombard GA, Weill D, Dhillon GS.

J Heart Lung Transplant. 2009 Feb;28(2):163-9. doi: 10.1016/j.healun.2008.11.907.

PMID:
19201342
4.

A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.

Kumar D, Husain S, Chen MH, Moussa G, Himsworth D, Manuel O, Studer S, Pakstis D, McCurry K, Doucette K, Pilewski J, Janeczko R, Humar A.

Transplantation. 2010 Apr 27;89(8):1028-33. doi: 10.1097/TP.0b013e3181d05a71.

PMID:
20075787
5.

Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.

Dickson RP, Erb-Downward JR, Freeman CM, Walker N, Scales BS, Beck JM, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB.

PLoS One. 2014 May 15;9(5):e97214. doi: 10.1371/journal.pone.0097214. eCollection 2014.

6.

Topographical continuity of bacterial populations in the healthy human respiratory tract.

Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG.

Am J Respir Crit Care Med. 2011 Oct 15;184(8):957-63. doi: 10.1164/rccm.201104-0655OC. Epub 2011 Jun 16.

7.

Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.

Gottlieb J, Mattner F, Weissbrodt H, Dierich M, Fuehner T, Strueber M, Simon A, Welte T.

Respir Med. 2009 May;103(5):743-9. doi: 10.1016/j.rmed.2008.11.015. Epub 2008 Dec 30.

9.

[Infection in lung transplantation].

Gavaldà J, Román A.

Enferm Infecc Microbiol Clin. 2007 Dec;25(10):639-49; quiz 650. Review. Spanish.

PMID:
18053475
10.

Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.

Riise GC, Andersson BA, Kjellström C, Martensson G, Nilsson FN, Ryd W, Scherstén H.

Eur Respir J. 1999 Nov;14(5):1123-30.

11.

Clinical spectrum of gram-positive infections in lung transplantation.

Gupta MR, Valentine VG, Walker JE Jr, Lombard GA, LaPlace SG, Seoane L, Taylor DE, Dhillon GS.

Transpl Infect Dis. 2009 Oct;11(5):424-31. doi: 10.1111/j.1399-3062.2009.00422.x. Epub 2009 Jul 29. Erratum in: Transpl Infect Dis. 2009 Dec;11(6):563.

PMID:
19659672
12.

Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease.

Cui L, Lucht L, Tipton L, Rogers MB, Fitch A, Kessinger C, Camp D, Kingsley L, Leo N, Greenblatt RM, Fong S, Stone S, Dermand JC, Kleerup EC, Huang L, Morris A, Ghedin E.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):932-42. doi: 10.1164/rccm.201409-1583OC.

13.

Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts.

Charlson ES, Bittinger K, Chen J, Diamond JM, Li H, Collman RG, Bushman FD.

PLoS One. 2012;7(9):e42786. doi: 10.1371/journal.pone.0042786. Epub 2012 Sep 6.

14.

Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.

Mamessier E, Milhe F, Badier M, Thomas P, Magnan A, Reynaud-Gaubert M.

J Heart Lung Transplant. 2006 May;25(5):523-32. Epub 2006 Apr 11.

PMID:
16678030
15.

Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients.

Soccal PM, Aubert JD, Bridevaux PO, Garbino J, Thomas Y, Rochat T, Rochat TS, Meylan P, Tapparel C, Kaiser L.

Clin Infect Dis. 2010 Jul 15;51(2):163-70. doi: 10.1086/653529.

PMID:
20524853
16.

Quantitative bacterial cultures and cytological examination of bronchoalveolar lavage specimens in dogs.

Peeters DE, McKiernan BC, Weisiger RM, Schaeffer DJ, Clercx C.

J Vet Intern Med. 2000 Sep-Oct;14(5):534-41. Erratum in: J Vet Intern Med 2001 Jan-Feb;15(1):66.

17.

Surveillance bronchoscopy in lung transplant recipients: risk versus benefit.

McWilliams TJ, Williams TJ, Whitford HM, Snell GI.

J Heart Lung Transplant. 2008 Nov;27(11):1203-9. doi: 10.1016/j.healun.2008.08.004. Epub 2008 Oct 1.

PMID:
18971092
18.

Viral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipients.

Young JC, Chehoud C, Bittinger K, Bailey A, Diamond JM, Cantu E, Haas AR, Abbas A, Frye L, Christie JD, Bushman FD, Collman RG.

Am J Transplant. 2015 Jan;15(1):200-9. doi: 10.1111/ajt.13031. Epub 2014 Nov 17.

19.

The impact of fluoroquinolone resistance of Gram-negative bacteria in respiratory secretions on the outcome of lung transplant (non-cystic fibrosis) recipients.

Shteinberg M, Raviv Y, Bishara J, Stein N, Rosengarten D, Bakal I, Kramer MR.

Clin Transplant. 2012 Nov-Dec;26(6):884-90. doi: 10.1111/j.1399-0012.2012.01665.x. Epub 2012 Jun 24.

PMID:
22724524
20.

Simkania negevensis and acute cellular rejection in lung transplant recipients.

Jamal AJ, Resende MR, Prochnow T, McGilvray I, Pilewski JM, Crespo MM, Singer LG, McCurry KR, Kolls JK, Keshavjee S, Liles WC, Husain S.

Clin Transplant. 2015 Aug;29(8):705-11. doi: 10.1111/ctr.12571. Epub 2015 Jul 20.

PMID:
26009941

Supplemental Content

Support Center